{"contentid": 488332, "importid": NaN, "name": "Repertoire Immune bags $189 million financing", "introduction": "Clinical-stage US biotech Repertoire Immune Medicines today announced the completion of a $189 million Series B financing.", "content": "<p>Clinical-stage US biotech Repertoire Immune Medicines today announced the completion of a $189 million Series B financing.</p>\n<p>Joining Flagship Pioneering, Repertoire&rsquo;s institutional founder and principal backer, are new and existing investors including Softbank Vision Fund 2, the Public Sector Pension Investment Board (PSP Investments), the Alaska Permanent Fund, Invus, and others.</p>\n<p>Proceeds from this financing will support further expansion of the company&rsquo;s proprietary DECODE discovery platform, accelerate its clinical and pre-clinical pipeline, expand Repertoire&rsquo;s team, and enhance its manufacturing capabilities. Founded by Flagship Pioneering, Repertoire has raised more than $350 million in the aggregate to date.</p>\n<p>The company is focussed on decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious disease, and other serious diseases,</p>\n<p>&ldquo;We are making tremendous progress toward unlocking the full potential of therapeutically modulating the immune system by decoding the interactions between T cells and antigens to create new classes of immune medicines for cancer, immune disorders, infectious diseases, and other serious diseases,&rdquo; said John Cox, chief executive of Repertoire.</p>\n<p>This financing also supports the advancement of multiple clinical programs in immuno-oncology using Repertoire&rsquo;s proprietary antigen-primed multi-clonal cytokine enhanced T cell products in solid tumors. The PRIME interleukin (IL)-15 program in advanced metastatic solid tumors is underway, with a data readout anticipated later this year. The PRIME IL-12 program in HPV-16+ solid tumors will be initiated by mid-year. Both clinical programs represent novel first of their kind immune medicines in oncology.</p>", "date": "2021-04-13 16:31:00", "meta_title": NaN, "meta_keywords": "Repertoire Immune Medicines, Financing, Series B, Flagship Pioneering", "meta_description": "Repertoire Immune bags $189 million financing", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-13 16:30:20", "updated": "2021-04-13 18:45:00", "access": NaN, "url": "https://www.thepharmaletter.com/article/repertoire-immune-bags-189-million-financing", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "repertoire_big.jpg", "image2id": "repertoire_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Immuno-oncology", "topic_tag": "Business Financing, One to Watch Companies, Research", "geography_tag": "USA", "company_tag": "Flagship Pioneering, Repertoire Immune Medicines, SoftBank Group Corp.", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-13 16:31:00"}